Eucrisa

2 % / W/W OintmentCanadaMarketedAuthorised 29 Aug 2018

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

EucrisaUnited States · 2% · ointment · Anacor Pharms INCSame brand
Staquis Ointment 2% w/wSingapore · 2% w/w · ointment · Pfizer Private LimitedSame strength and form
CrisaboroleUnited States · 2% · ointment · Macleods Pharms LTDSame form
StaquisEuropean Union · Pfizer Europe MA EEIGSame substance
StaquisSaudi Arabia · Pharmacia UpjohnSame substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Crisaborole
Strength: 2 % / W/W
Dosage form: Ointment
Route: Topical
Register: Canada (Health Canada)
Status: Marketed
Authorised: 29 Aug 2018
Registration: DIN 02476991
Marketing authorisation holder: Pfizer Canada Ulc
ATC code: D11AH06
Group: Dermatologicals
Supply: PRESCRIPTION